Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
Abstract Necroptosis is a form of regulated cell death that has been implicated in multiple diseases. TNF-induced necroptosis is regulated by necrosomes, complexes consisting of RIPK1, RIPK3 and MLKL. In this study, by screening of a small-compound library, we identified dozens of compounds that inh...
Main Authors: | Fangmin Huang, Jiankun Liang, Yingying Lin, Yushi Chen, Fen Hu, Jianting Feng, Qiang Zeng, Zeteng Han, Qiaofa Lin, Yan Li, Jingyi Li, Lanqin Wu, Lisheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-023-05353-5 |
Similar Items
-
Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL
by: Jingyi Li, et al.
Published: (2024-02-01) -
Identification of Piperlongumine as Potent Inhibitor of Necroptosis
by: He X, et al.
Published: (2023-05-01) -
Repositioning linifanib as a potent anti-necroptosis agent for sepsis
by: Liang Yu, et al.
Published: (2023-02-01) -
Crystal structure of the FLT3 kinase domain bound to the inhibitor Quizartinib (AC220).
by: Julie A Zorn, et al.
Published: (2015-01-01) -
Quizartinib (AC220): a promising option for acute myeloid leukemia
by: Zhou F, et al.
Published: (2019-04-01)